Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer

      Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer

      Ruby Khatun Khatun3 Sept 2018 10:30 AM IST
      Mumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new...
      Mankind Pharma gives Rs 1 crore for Kerala help

      Mankind Pharma gives Rs 1 crore for Kerala help

      Ruby Khatun Khatun3 Sept 2018 10:15 AM IST
      New Delhi: Mankind Pharma, a quality-driven pharmaceutical company in India, has donated Rs 1 crore towards Kerala's Flood Relief Fund.The company...
      Pharma sector may give 25 percent returns in pre-election year: Report

      Pharma sector may give 25 percent returns in pre-election year: Report

      Ruby Khatun Khatun3 Sept 2018 10:00 AM IST
      New Delhi: The healthcare sector has long been the underperformer but is likely to give as much as 25 percent returns in the pre-election year, while...
      FDA approves two new HIV drugs from Merck

      FDA approves two new HIV drugs from Merck

      Ruby Khatun Khatun3 Sept 2018 9:30 AM IST
      Merck & Co Inc said the U.S. Food And Drug Administration approved two of its HIV oral drugs, nearly two months ahead of schedule.The drugs have...
      Pharma Giants looking to acquire Bharat Serums and Vaccines: Report

      Pharma Giants looking to acquire Bharat Serums and Vaccines: Report

      Ruby Khatun Khatun2 Sept 2018 11:59 AM IST
      MUMBAI: Several domestic firms are vying the race to by Bharat Serums and Vaccines Ltd (BSV).In order to acquire the Mumbai based vaccine maker Bharat...
      Cadila Healthcare subsidiary gets 5 observations from USFDA

      Cadila Healthcare subsidiary gets 5 observations from USFDA

      Ruby Khatun Khatun2 Sept 2018 10:45 AM IST
      Mumbai: Pharma Major Cadila Healthcare said that USFDA inspected the injectables manufacturing facility of Liva Pharmaceuticals Ltd a 100 percent...
      Suven Life Sciences secures Product Patents in China, Eurasia

      Suven Life Sciences secures Product Patents in China, Eurasia

      Ruby Khatun Khatun2 Sept 2018 10:30 AM IST
      Mumbai: Pharma Major, Suven Life Sciences Ltd announced the grant of one product patent from China and one product patent from Eurasia corresponding...
      FDA recalls Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles

      FDA recalls Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles

      Ruby Khatun Khatun2 Sept 2018 10:00 AM IST
      The U.S. Food and Drug Administration (FDA) is warning consumers and healthcare professionals about a voluntary recall of one lot of Montelukast...
      HCA Healthcare to buy Mission Health for 1.5 billion dollar

      HCA Healthcare to buy Mission Health for 1.5 billion dollar

      Ruby Khatun Khatun2 Sept 2018 9:45 AM IST
      HCA Healthcare Inc, the biggest hospital operator in the United States, said on Friday it would buy Mission Health, a non-profit health system in...
      Chinas Fosun Pharma stock tumbles after regulators spot check on subsidiary

      China's Fosun Pharma stock tumbles after regulator's spot check on subsidiary

      Ruby Khatun Khatun2 Sept 2018 9:30 AM IST
      SHANGHAI: Shanghai Fosun Pharmaceutical Group Co Ltd saw its shares tumble by as much as 10 percent on Friday after it said regulators had made an...
      Ban on Oxytocin manufacture, sale: Delhi High Court suspends ban till October 1

      Ban on Oxytocin manufacture, sale: Delhi High Court suspends ban till October 1

      Ruby Khatun Khatun1 Sept 2018 1:44 PM IST
      The ban on the production and sale of the Oxytocin formulation has been suspended by the Delhi High Court till October 1st, 2018.New Delhi: The Delhi...
      Unique Punishment: High Court asks Pharma Company to deposit Rs 1.50 crore towards Kerala Relief Fund

      Unique Punishment: High Court asks Pharma Company to deposit Rs 1.50 crore towards Kerala Relief Fund

      Ruby Khatun Khatun1 Sept 2018 12:01 PM IST
      Mumbai: The Bombay High Court has ordered a pharmaceutical company to deposit Rs 1.50 crore towards the Kerala Chief Minister's Fund for flood relief...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok